|
US5457208A
(en)
|
1993-06-21 |
1995-10-10 |
Regents Of The University Of Minnesota |
Kappa opioid receptor antagonists
|
|
ES2189759T3
(es)
|
1999-05-12 |
2003-07-16 |
Hoffmann La Roche |
Derivados de imidazoiacepina.
|
|
US20020052365A1
(en)
|
2000-10-05 |
2002-05-02 |
Mohler Hanns |
Selective anxiolytic therapeutic agents
|
|
JP2004518654A
(ja)
|
2000-12-21 |
2004-06-24 |
ザ マクレーン ホスピタル コーポレーション |
鬱病の治療法
|
|
US6974824B2
(en)
|
2001-01-08 |
2005-12-13 |
Research Triangle Institute |
Kappa opioid receptor ligands
|
|
WO2003082832A2
(en)
|
2002-03-28 |
2003-10-09 |
Wisys Technology Foundation, Inc. |
Anxiolytic agents with reduced sedative and ataxic effects
|
|
PT2208727E
(pt)
|
2002-09-19 |
2012-10-11 |
Lilly Co Eli |
Éteres diarílicos como antagonista do receptor opióide
|
|
EP1606275B1
(en)
|
2003-03-07 |
2008-08-27 |
Eli Lilly And Company |
Opioid receptor antagonists
|
|
WO2004080968A1
(en)
|
2003-03-07 |
2004-09-23 |
Eli Lilly And Company |
6-substituted nicotinamide derivatives as opioid receptor antagonists
|
|
CN1890208A
(zh)
|
2003-12-12 |
2007-01-03 |
伊莱利利公司 |
类鸦片受体拮抗剂
|
|
BRPI0417714A
(pt)
|
2003-12-22 |
2007-03-20 |
Lilly Co Eli |
composto, composição farmacêutica, e, uso de um composto
|
|
JP2007528898A
(ja)
|
2004-03-12 |
2007-10-18 |
イーライ リリー アンド カンパニー |
オピオイド受容体拮抗物質
|
|
AU2005222640A1
(en)
|
2004-03-12 |
2005-09-29 |
The Mclean Hospital Corporation |
Salvinorin derivatives and uses thereof
|
|
US7381750B2
(en)
|
2004-03-12 |
2008-06-03 |
Eli Lilly And Company |
Amino-phenoxymethyl-benzamide opioid receptor antagonists
|
|
US7378448B2
(en)
|
2004-03-15 |
2008-05-27 |
Eli Lilly And Company |
Diphenylether amide derivatives as opioid receptor antagonists
|
|
WO2005090303A1
(en)
|
2004-03-15 |
2005-09-29 |
Eli Lilly And Company |
4- (5- (aminomethyl) -indole-1-ylmethyl) -benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity
|
|
US8551986B2
(en)
|
2005-12-08 |
2013-10-08 |
The Mclean Hospital Corporation |
Treatment of sequelae of psychiatric disorders
|
|
PL2001456T3
(pl)
|
2006-04-04 |
2010-05-31 |
Emodys Gmbh |
Zastosowanie kompozycji zawierających antagonistę receptora opioidowego kappa do leczenia zaburzeń dysocjacyjnych
|
|
US8633175B2
(en)
|
2006-08-09 |
2014-01-21 |
Glaxosmithkline Llc |
Compounds as antagonists or inverse agonists at opioid receptors
|
|
JP2010500372A
(ja)
|
2006-08-09 |
2010-01-07 |
スミスクライン ビーチャム コーポレーション |
オピオイド受容体に対するアンタゴニストまたはインバースアゴニストとしての新規化合物
|
|
MX2009002527A
(es)
|
2006-09-08 |
2009-03-20 |
Pfizer Prod Inc |
Derivados de eter diarilico y usos de los mismos.
|
|
US7709522B2
(en)
|
2008-01-22 |
2010-05-04 |
Eli Lilly And Company |
Kappa selective opioid receptor antagonist
|
|
EP3566697B1
(en)
*
|
2009-11-09 |
2024-09-11 |
Wyeth LLC |
Tablet formulations of neratinib maleate
|
|
US20130303497A1
(en)
|
2010-08-05 |
2013-11-14 |
Conrig Pharma Aps |
Deuterated 5-ht1a receptor agonists
|
|
WO2013086496A2
(en)
|
2011-12-09 |
2013-06-13 |
Research Triangle Institute |
1-substituted 4-arylpiperazine as kappa opioid receptor antagonists
|
|
CA2933733A1
(en)
|
2013-12-20 |
2015-06-25 |
Connie Sanchez Morillo |
Use of an opioid receptor antagonist with kappa-activity and vortioxetine for treatment of depressive disorder with melancholic features
|
|
US10377698B2
(en)
|
2015-03-30 |
2019-08-13 |
University Of Innsbruck |
Diphenethylamine derivatives which are inter alia useful as analgesics and method for their production
|
|
WO2016191763A2
(en)
|
2015-05-28 |
2016-12-01 |
Georgetown University |
Use of methadone metabolites for treatment of anxiety and depression
|
|
TWI804919B
(zh)
*
|
2015-06-30 |
2023-06-11 |
美商建南德克公司 |
含藥物之立即釋放錠劑及形成該錠劑的方法
|
|
EP3468540A4
(en)
|
2016-06-13 |
2020-03-18 |
Board Of Regents Of the University Of Texas System |
PHARMACEUTICAL COMPOSITIONS AND METHOD FOR TREATING PAIN
|
|
EP3490542A4
(en)
|
2016-07-26 |
2020-07-08 |
Flagship Pioneering Innovations V, Inc. |
NEUROMODULATION COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER BY MODULATION OF AN ANTI-CANCER RESPONSE
|
|
AU2017325870B2
(en)
|
2016-09-16 |
2021-07-22 |
Research Traingle Institute |
Tetrahydroisoquinoline kappa opioid antagonists
|
|
US10316021B2
(en)
|
2016-11-28 |
2019-06-11 |
Pfizer Inc. |
Heteroarylphenoxy benzamide kappa opioid ligands
|
|
DK3596069T3
(da)
|
2017-03-17 |
2022-08-01 |
Scripps Research Inst |
Kappa-opioid-receptor-antagonister og produkter og fremgangsmåder relateret dertil
|
|
SG10201802129QA
(en)
*
|
2017-07-05 |
2019-02-27 |
Frimline Private Ltd |
A pharmaceutical composition for neuropathic pain
|
|
US20190255036A1
(en)
|
2018-02-16 |
2019-08-22 |
Alexander Kariman |
Compound and method for reducing neuropathic pain and depression
|
|
US11820835B2
(en)
|
2018-03-23 |
2023-11-21 |
University Of Kansas |
Cyclic tetrapeptide analogs
|
|
US11491144B2
(en)
|
2018-03-30 |
2022-11-08 |
The Florida State University Research Foundation, Incorporated |
Methods of treating fragile X mental retardation syndrome
|
|
US11103171B2
(en)
|
2018-10-23 |
2021-08-31 |
BlackThor Therapeutics, Ine. |
Systems and methods for screening, diagnosing, and stratifying patients
|
|
US20200171025A1
(en)
*
|
2018-11-29 |
2020-06-04 |
Srinivasa Rao Parella |
Pharmaceutical composition comprising brexpiprazole and process for preparation thereof
|
|
US11266627B1
(en)
|
2021-05-04 |
2022-03-08 |
Janssen Pharmaceuticals, Inc. |
Compositions and methods for the treatment of depression
|
|
CN114195693A
(zh)
|
2020-09-17 |
2022-03-18 |
广东东阳光药业有限公司 |
一种酰胺化合物的晶型及其制备方法
|
|
US12161622B2
(en)
|
2021-05-04 |
2024-12-10 |
Janssen Pharmaceuticals, Inc. |
Compositions and methods for the treatment of depression
|
|
WO2022234457A1
(en)
*
|
2021-05-04 |
2022-11-10 |
Janssen Pharmaceuticals, Inc. |
Compositions and methods for the treatment of depression
|
|
CA3254546A1
(en)
|
2022-03-07 |
2023-09-14 |
Janssen Pharmaceuticals, Inc. |
COMPOSITIONS CONTAINING ATICAPRANT
|
|
EP4489748A1
(en)
|
2022-03-07 |
2025-01-15 |
Janssen Pharmaceuticals, Inc. |
Pure forms of crystalline aticaprant
|
|
CN119156211A
(zh)
|
2022-03-07 |
2024-12-17 |
杨森制药公司 |
用于治疗重性抑郁障碍的多晶型形式的阿替卡普兰
|